Publications by authors named "Lot A Devriese"

Claim this Profile
N
Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.
Sabine E Breukers, Joleen J H Traets, Stan W van Dijk, Mercedes Machuca Ostos, Itske Fraterman, Lot A Devriese

Nat Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International network for sinonasal cancer research (INSICA): a collaborative group to advance research and clinical trials for rare sinonasal malignancies.
Nyall R London, Glenn J Hanna, Neal S Akhave, Garret Choby, Lot A Devriese

J Natl Cancer Inst· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial.
Sabine E Breukers, Robert D Crommelin, Laura A Smit, Jan Paul de Boer, Arash Navran, Lot A Devriese

Eur J Nucl Med Mol Imaging· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sinonasal Intestinal-Type Adenocarcinoma in the Netherlands: A Nationwide Study (2008-2022).
Lise J van de Velde, Gerben E Breimer, W F Julius Scheurleer, Mischa de Ridder, Lot A Devriese

Head Neck· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer.
Caroline Even, Kevin J Harrington, Erminia Massarelli, Simon Laban, Jérôme Fayette, Lot A Devriese

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head and Neck Cancer in Suriname: An Epidemiologic Review of Clinical and Pathologic Features of Patients Treated Between 2009 and 2021.
Sangeeta K Bisheshar, Els T M Dams, Mikel Chan, Lorian Slagter-Menkema, Harie Basdew, Lot A Devriese

JCO Glob Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of hydration schedules on dose-limiting toxicity in patients with head and neck squamous cell carcinoma treated with cisplatin.
Anouk W M A Schaeffers, Cassimy B van Neerven, Dorieke van Balen, Mirjam Crul, Marije Slingerland, Lot A Devriese

Br J Clin Pharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of cisplatin-induced hearing loss in different durations of infusion and volume of hydration schedules in head and neck squamous cell carcinoma patients treated with cisplatin-based chemoradiation.
Anouk V M Burger, Melissa A Koot, Dorieke E M van Balen, Anouk W M A Schaeffers, Charlotte L Zuur, Lot A Devriese

Oral Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study.
Shailender Bhatia, Suzanne L Topalian, William Sharfman, Tim Meyer, Neil Steven, Lot A Devriese

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sinonasal Squamous Cell Carcinoma in the Netherlands: A Population-Based Study of 568 Cases Diagnosed in 2008-2021.
Lise J van de Velde, W F Julius Scheurleer, W Weibel Braunius, Caroline M Speksnijder, Mischa de Ridder, Lot A Devriese

Head Neck· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin-based chemoradiotherapy in patients with head and neck squamous cell carcinoma.
Anouk W M A Schaeffers, Anouk V M Burger, Charlotte W Duinkerken, Klaske E van Sluis, Jan Paul de Boer, Lot A Devriese

Head Neck· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sinonasal mucosal melanoma in The Netherlands between 2001 and 2021: a clinical and epidemiological overview of 320 cases.
W F Julius Scheurleer, Lise J van de Velde, Lot A Devriese, Mischa de Ridder, Marieke W J Louwman

Eur Arch Otorhinolaryngol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol.
Laurien J Zeverijn, Birgit S Geurts, Thomas W Battaglia, Jade M van Berge Henegouwen, Gijs F de Wit, Lot A Devriese

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How do patients with head and neck cancer and low skeletal muscle mass experience cisplatin-based chemoradiotherapy? A qualitative study.
Anouk W M A Schaeffers, Maartje A van Beers, Lot A Devriese, F W José Klomp, Chantal F M Westerink-van den Brink

Support Care Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Squamous cell carcinoma of the nasal vestibule in the Netherlands: A clinical and epidemiological review of 763 cases (2008-2021).
Lise J van de Velde, W F Julius Scheurleer, W Weibel Braunius, Lot A Devriese, Mischa de Ridder

Head Neck· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial.
Ana Oaknin, Kathleen Moore, Tim Meyer, José López-Picazo González, Lot A Devriese

Lancet Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol.
Karlijn Verkerk, Birgit S Geurts, Laurien J Zeverijn, Vincent van der Noort, Henk M W Verheul, Lot A Devriese

Lancet Reg Health Eur· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in the association of time to treatment initiation and survival according to various head and neck cancer sites in a nationwide cohort.
Michaël H Frank, Boukje A C van Dijk, Rosanne C Schoonbeek, Jaap Zindler, Lot A Devriese

Radiother Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol.
Anouk W M A Schaeffers, Lot A Devriese, Carla H van Gils, Jan Willem Dankbaar, Jens Voortman

PLoS One· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and Treatment-Related Challenges in Sinonasal Teratocarcinosarcoma: A Report of Three Cases.
W F Julius Scheurleer, Weibel W Braunius, Bernard M Tijink, Luuk M Janssen, Frank A Pameijer, Lot A Devriese

Case Rep Otolaryngol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Accurate detection of circulating tumor DNA using nanopore consensus sequencing.
Alessio Marcozzi, Myrthe Jager, Martin Elferink, Roy Straver, Joost H van Ginkel, Lot A Devriese

NPJ Genom Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification.
Rosemary Millen, Willem W B De Kort, Mandy Koomen, Gijs J F van Son, Roán Gobits, Lot A Devriese

Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term oncological follow-up after mold-based pulsed dose rate brachytherapy for early stage squamous cell carcinoma of the nasal vestibule: A single center experience of 68 patients over a 17-year period.
W F Julius Scheurleer, Homan Dehnad, W Weibel Braunius, Luuk M Janssen, Bernard M Tijink, Lot A Devriese

Brachytherapy· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumors.
Wesley S van de Geer, Ron H J Mathijssen, Job van Riet, Neeltje Steeghs, Mariette Labots, Lot A Devriese

Biomed Pharmacother· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metachronous malignancies after response to checkpoint inhibition.
Mirjam A de Visser, Francois B Verschaeve, Lot A Devriese, Bart Neyns, Karijn P M Suijkerbuijk

Eur J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis